Novo Nordisk Foundation
Regenerative Medicine Catalyst Grants 2026
Two-phase process: Phase I concept note, then invited Phase II full application. No specific deadline date stated on page.
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | Up to DKK 5M (standard) / Up to DKK 10M (collaborative); total pool DKK 100M |
| Duration | Up to 3 years |
| Consortium | Optional — collaborative projects require at least 1 international co-applicant from a different country than the main applicant |
| Application | 2-stage: Phase I concept note (internal triage) → Phase II full application (external peer review) |
| TRL | 3-6 |
| Eligible countries | DKSENOFIIS |
Eligibility & scope
Main applicant must be an established investigator at a university, hospital, or non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, Iceland, Greenland, Faroe Islands). Translational RM research only; fundamental/discovery-phase, CAR-T/NK cell, and gene therapy projects are out of scope. Standard grants up to DKK 5M; collaborative projects (with international co-applicant) up to DKK 10M. For-profit partners may collaborate but cannot receive direct funding.
More from Novo Nordisk Foundation
Non-Diabetic Endocrinology Collaborative Grants 2026
Deadline: 3 Jun 2026DKK 5M–10M per grant (total pool up to DKK 53M)Project grants in Endocrinology and Metabolism – Nordic Region
Deadline: 4 Jun 2026Up to DKK 4.5 million per grantNovo Nordisk NERD Programme 2026
Deadline: 10 Jun 2026Up to DKK 10M (~€1.3M)Novo Nordisk Data Science Collaborative Research 2026
Deadline: 10 Jun 2026Up to DKK 30M (~€4M)Start Package Grants – For faculty recruitment Q3 2026
Deadline: 25 Jun 2026Up to DKK 10 million per grant
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free